Cargando…
mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in December of 2019 and is responsible for millions of infections and deaths across the globe. Vaccination against SARS-CoV-2 has proven effective to contain the spread of the virus and reduce disease...
Autores principales: | Kackos, Christina M., Surman, Sherri L., Jones, Bart G., Sealy, Robert E., Jeevan, Trushar, Davitt, Christopher J. H., Pustylnikov, Sergei, Darling, Tamarand L., Boon, Adrianus C. M., Hurwitz, Julia L., Samsa, Marcelo M., Webby, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927305/ https://www.ncbi.nlm.nih.gov/pubmed/36695597 http://dx.doi.org/10.1128/spectrum.04240-22 |
Ejemplares similares
-
Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection
por: Kackos, Christina M., et al.
Publicado: (2023) -
Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013) -
Might Routine Vitamin A Monitoring in Cystic Fibrosis Patients Reduce Virus-Mediated Lung Pathology?
por: Sealy, Robert E., et al.
Publicado: (2021) -
Nuclear Receptors, Ligands and the Mammalian B Cell
por: Jones, Bart G., et al.
Publicado: (2020) -
Respiratory Tract Epithelial Cells Express Retinaldehyde Dehydrogenase ALDH1A and Enhance IgA Production by Stimulated B Cells in the Presence of Vitamin A
por: Rudraraju, Rajeev, et al.
Publicado: (2014)